Target intelligence / Profile preview

Tetrapeptide repeat homeobox-like (TPRXL)

Target
TPRXL
Molecular classification
Pseudogene, Transcription factor (putative), Homeobox gene family
01

Overview

Tetrapeptide repeat homeobox-like (TPRXL) is a human gene considered a member of the homeobox gene family, encoding a putative DNA-binding protein with a homeodomain[1][3][5]. The gene is denoted as a **pseudogene**, meaning it is widely *thought not to code for a functional protein* in humans[3][6]. It has been characterized alongside functional homeobox genes, which typically play roles in transcriptional regulation during early development, including zygotic genome activation[3][8]. However, unlike its paralog TPRX1, there is *no conclusive evidence* that the TPRXL locus encodes an active protein or is a therapeutic target. At least one report identified TPRXL as a potential biomarker in myelodysplastic syndrome, but this has not been broadly validated[7]. **Key notes:** - TPRXL is a **pseudogene**; its product is likely non-functional in most if not all humans[3][6]. - Not considered a therapeutic target such as receptor, enzyme, or transporter[3][6]. - Lists as a putative transcription factor are due to sequence homology, not demonstrated activity[3][1]. - No known interacting drugs, mechanisms of action, or associated safety concerns. - Some aliases or alternative identifiers may refer to earlier classifications or predictions, but current annotations consistently list as a pseudogene[3][6]. - Its close paralog, TPRX1 (Tetrapeptide repeat homeobox 1), *is* a protein-coding gene with established transcription factor functions[2]. If you are looking for a functional homeobox transcription factor, TPRX1 may be the intended target rather than TPRXL.

Other names
TPRXLTPRX3Ptetra-peptide repeat homeobox-likeFLJ35107
02

Biological functions

Potential involvement in early embryonic development (inferred; canonical TPRX proteins are linked to transcriptional activation in zygotic genome activation)DNA-binding (homeodomain) (inferred)
03

Disease associations

Potential biomarker in myelodysplastic syndrome (weak evidence)No well-established disease role
04

Biomarkers

Has been proposed as a potential biomarker in myelodysplastic syndrome (MDS)

Beyond the preview

Go deeper on Tetrapeptide repeat homeobox-like (TPRXL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetrapeptide repeat homeobox-like (TPRXL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call